- Home
- SMSI vs SNSE Comparison
SMSI vs SNSE Comparison
Compare SMSI & SNSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SMSI | SNSE |
|---|---|---|
| Founded | 1982 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1M | 12.2M |
| IPO Year | 2017 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SMSI | SNSE |
|---|---|---|
| Price | $0.56 | $30.21 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $72.50 |
| AVG Volume (30 Days) | 85.8K | ★ 569.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1.64 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $20,555,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $46.15 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.41 | $0.25 |
| 52 Week High | $1.32 | $36.76 |
Technical Indicators
Market Signals| Indicator | SMSI | SNSE |
|---|---|---|
| Relative Strength Index (RSI) | 60.96 | 74.47 |
| Support Level | $0.55 | $7.94 |
| Resistance Level | $0.64 | N/A |
| Average True Range (ATR) | 0.04 | 3.55 |
| MACD | 0.01 | 1.85 |
| Stochastic Oscillator | 94.46 | 77.79 |
Price Performance
Historical ComparisonAbout SMSI Smith Micro Software Inc.
Smith Micro Software Inc is a provider of software solutions. It develops and markets wireless solutions for wireless service providers, mobile device and chipset manufacturers, and enterprise businesses. Its portfolio includes family safety software solutions to support families in the digital age and creating, sharing, and monetizing rich content, such as visual voice messaging, retail content display optimization and performance analytics on any product set. The company's only reportable segment is Wireless. Wireless segment includes the Family Safety (which includes SafePath), CommSuite, and ViewSpot families of products.
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).